GoingToMeet

Dear Colleague,
Interest and integration of running clinical trials in Asia has grown extensively in the past few years. This immense growth, while beneficial for organizations looking to expedite trials through shorter timelines and lower costs, seems to have come faster than many of the countries can accommodate- while they accept more and more trials, their regulatory authorities are slow to create regulations to accommodate the trials and its participants. In addition to a host of other obstacles, ultimately each country's regulations are different, resulting in US companies expending additional time and resources to plan and conduct clinical trials abroad. With so much variation and growth in this arena, what solutions are available to pharmaceutical organizations to ensure that their outsourced clinical trials will be run within regulatory guidelines in an efficient, cost-effective manner?


ExL Pharma is proud to present the Clinical Trials in Asia event- a two-day conference dedicated to providing solutions for overcoming obstacles associated with outsourcing clinical trials to Asia. Strategic presentations focused on trials in China and India allow attendees to hear the latest updates on regulations, growth and tactics for working effectively through language and cultural barriers to guarantee effective completion of trials abroad. We look forward to welcoming you to New Jersey in September!


Sincerely,
Sarah Ide
Conference Director
ExL Pharma